Report Detail
Global Radiopharmaceuticals in Nuclear Medicine Market Research Report 2020 by Manufacturers, Regions, Types and Applications
- RnM3949723 |
- 14 April, 2020 |
- Global |
- 125 Pages |
- XYZResearch |
- Medical Devices & Consumables
In this report,XYZ-research offers a comprehensive analysis of key market trends in the global Radiopharmaceuticals in Nuclear Medicine market. It also includes discussion on historical trends, current market status, competitive landscape, growth opportunities and challenges which are backed by factful feedbacks. The report extensively provides quantitative analysis of the industry from 2014-2026,by Region, Type, Application. Consumption assessment by application, production by type in different regions. Furthermore, the report quantifies the market share held by the major players of the industry and provides an in-depth view of the competitive landscape. The market size in terms of revenue (USD) and production is calculated for the study period along with the details of the factors affecting the market growth (drivers and restraints). The worldwide market for Radiopharmaceuticals in Nuclear Medicinemarket will reach xxx Million USD in 2020 and is expected to grow at a CAGR of xx% 2021-2026.
Geographically, global Radiopharmaceuticals in Nuclear Medicine market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Bracco Imaging S.P.A.
Cambridge Isotope Laboratories, Inc.
Cardinal Health, Inc.
Covidien, Plc
Eczacibasi-Monrol
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary Of General Electric Company)
IBA Group
Isotec, Inc. (Sigma-Aldrich)
Lantheus Medical Imaging, Inc.
Nordion, Inc.
Ntp Radioisotopes (Pty), Ltd.
Siemens Healthcare (Subsidiary Of Siemens AG)
Taiyo Nippon Sanso Corporation
Urenco Limited
Rotem Industries, Ltd., Inc.
Australian Nuclear Association And Technology Organization (ANSTO)
Board of Radiation And Isotope Technology (BRIT)
Institute of Atomic Energy Polatom Radioisotope Centre
Institute of Isotopes Co., Ltd.
Institute Of Radioelement (IRE)
On the basis of product, we research the production, revenue, price, market share and growth rate, primarily split into
Diagnostic Radiopharmaceuticals
Therapy Radiopharmaceuticals
Enriched Stable Isotopes
For the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Radiopharmaceuticals in Nuclear Medicine for each application, including
Diagnostic Application
Therapeutic Application
Research
Pharmaceutical
Other
Production, consumption, revenue, market share and growth rate are the key targets for Radiopharmaceuticals in Nuclear Medicine from 2014 to 2026 (forecast) in these regions
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
1 Report Overview
- 1.1 Definition
- 1.2 Manufacturers and Regions Overview
- 1.2.1 Manufacturers Overview
- 1.2.2 Regions Overview
- 1.3 Type Overview
- 1.4 Application Overview
- 1.5 Industrial Chain
- 1.5.1 Radiopharmaceuticals in Nuclear Medicine Overall Industrial Chain
- 1.5.2 Upstream
- 1.5.3 Downstream
- 1.5.4 Economic/Political Environment
2 Global Radiopharmaceuticals in Nuclear Medicine Market Assesment by Types
- 2.1 Overall Market Performance
- 2.1.1 Product Type Market Performance (Volume)
- 2.1.2 Product Type Market Performance (Value)
- 2.2 China Radiopharmaceuticals in Nuclear Medicine Market Performance
- 2.3 USA Radiopharmaceuticals in Nuclear Medicine Market Performance
- 2.4 Europe Radiopharmaceuticals in Nuclear Medicine Market Performance
- 2.5 Japan Radiopharmaceuticals in Nuclear Medicine Market Performance
- 2.6 Korea Radiopharmaceuticals in Nuclear Medicine Market Performance
- 2.7 India Radiopharmaceuticals in Nuclear Medicine Market Performance
- 2.8 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Performance
- 2.9 South America Radiopharmaceuticals in Nuclear Medicine Market Performance
3 Global Radiopharmaceuticals in Nuclear Medicine Market Assesment by Application
- 3.1 Overall Market Performance (Volume)
- 3.2 China Radiopharmaceuticals in Nuclear Medicine Market Performance (Volume)
- 3.3 USA Radiopharmaceuticals in Nuclear Medicine Market Performance (Volume)
- 3.4 Europe Radiopharmaceuticals in Nuclear Medicine Market Performance (Volume)
- 3.5 Japan Radiopharmaceuticals in Nuclear Medicine Market Performance (Volume)
- 3.6 Korea Radiopharmaceuticals in Nuclear Medicine Market Performance (Volume)
- 3.7 India Radiopharmaceuticals in Nuclear Medicine Market Performance (Volume)
- 3.8 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Performance (Volume)
- 3.9 South America Radiopharmaceuticals in Nuclear Medicine Market Performance (Volume)
4 Competitive Analysis
- 4.1 Bracco Imaging S.P.A.
- 4.1.1 Bracco Imaging S.P.A. Profiles
- 4.1.2 Bracco Imaging S.P.A. Product Information
- 4.1.3 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Production, Revenue, Price and Gross Margin
- 4.1.4 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Business Performance
- 4.1.5 SWOT Analysis
- 4.2 Cambridge Isotope Laboratories, Inc.
- 4.2.1 Cambridge Isotope Laboratories, Inc. Profiles
- 4.2.2 Cambridge Isotope Laboratories, Inc. Product Information
- 4.2.3 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Production, Revenue, Price and Gross Margin
- 4.2.4 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Business Performance
- 4.2.5 SWOT Analysis
- 4.3 Cardinal Health, Inc.
- 4.3.1 Cardinal Health, Inc. Profiles
- 4.3.2 Cardinal Health, Inc. Product Information
- 4.3.3 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Production, Revenue, Price and Gross Margin
- 4.3.4 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Business Performance
- 4.3.5 SWOT Analysis
- 4.4 Covidien, Plc
- 4.4.1 Covidien, Plc Profiles
- 4.4.2 Covidien, Plc Product Information
- 4.4.3 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Production, Revenue, Price and Gross Margin
- 4.4.4 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Business Performance
- 4.4.5 SWOT Analysis
- 4.5 Eczacibasi-Monrol
- 4.5.1 Eczacibasi-Monrol Profiles
- 4.5.2 Eczacibasi-Monrol Product Information
- 4.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Production, Revenue, Price and Gross Margin
- 4.5.4 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Business Performance
- 4.5.5 SWOT Analysis
- 4.6 Fujifilm Holdings Corporation
- 4.6.1 Fujifilm Holdings Corporation Profiles
- 4.6.2 Fujifilm Holdings Corporation Product Information
- 4.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Production, Revenue, Price and Gross Margin
- 4.6.4 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Business Performance
- 4.6.5 SWOT Analysis
- 4.7 GE Healthcare (Subsidiary Of General Electric Company)
- 4.7.1 GE Healthcare (Subsidiary Of General Electric Company) Profiles
- 4.7.2 GE Healthcare (Subsidiary Of General Electric Company) Product Information
- 4.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Production, Revenue, Price and Gross Margin
- 4.7.4 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Business Performance
- 4.7.5 SWOT Analysis
- 4.8 IBA Group
- 4.8.1 IBA Group Profiles
- 4.8.2 IBA Group Product Information
- 4.8.3 IBA Group Radiopharmaceuticals in Nuclear Medicine Production, Revenue, Price and Gross Margin
- 4.8.4 IBA Group Radiopharmaceuticals in Nuclear Medicine Business Performance
- 4.8.5 SWOT Analysis
- 4.9 Isotec, Inc. (Sigma-Aldrich)
- 4.9.1 Isotec, Inc. (Sigma-Aldrich) Profiles
- 4.9.2 Isotec, Inc. (Sigma-Aldrich) Product Information
- 4.9.3 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Production, Revenue, Price and Gross Margin
- 4.9.4 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Business Performance
- 4.9.5 SWOT Analysis
- 4.10 Lantheus Medical Imaging, Inc.
- 4.10.1 Lantheus Medical Imaging, Inc. Profiles
- 4.10.2 Lantheus Medical Imaging, Inc. Product Information
- 4.10.3 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Production, Revenue, Price and Gross Margin
- 4.10.4 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Business Performance
- 4.10.5 SWOT Analysis
- 4.11 Nordion, Inc.
- 4.12 Ntp Radioisotopes (Pty), Ltd.
- 4.13 Siemens Healthcare (Subsidiary Of Siemens AG)
- 4.14 Taiyo Nippon Sanso Corporation
- 4.15 Urenco Limited
- 4.16 Rotem Industries, Ltd., Inc.
- 4.17 Australian Nuclear Association And Technology Organization (ANSTO)
- 4.18 Board of Radiation And Isotope Technology (BRIT)
- 4.19 Institute of Atomic Energy Polatom Radioisotope Centre
- 4.20 Institute of Isotopes Co., Ltd.
- 4.21 Institute Of Radioelement (IRE)
5 Competitive Landscape
- 5.1 Global Radiopharmaceuticals in Nuclear Medicine Production (K Units) and Market Share by Manufacturers (2014-2020)
- 5.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) and Market Share by Manufacturers (2014-2020)
- 5.3 Global Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers (2014-2020)
- 5.4 Global Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers (2014-2020)
- 5.5 Market Concentration
6 Global Radiopharmaceuticals in Nuclear Medicine Market Assessment by Regions
- 6.1 Global Radiopharmaceuticals in Nuclear Medicine Production (K Units) and Market Share by Regions (2014-2020)
- 6.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) and Market Share by Regions (2014-2020)
- 6.3 Global Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) by Regions (2014-2020)
- 6.4 Global Radiopharmaceuticals in Nuclear Medicine Gross Margin by Regions (2014-2020)
7 Radiopharmaceuticals in Nuclear Medicine Regional Analysis
- 7.1 China Radiopharmaceuticals in Nuclear Medicine Production, Revenue and Growth Rate (2014-2020)
- 7.2 USA Radiopharmaceuticals in Nuclear Medicine Production, Revenue and Growth Rate (2014-2020)
- 7.3 Europe Radiopharmaceuticals in Nuclear Medicine Production, Revenue and Growth Rate (2014-2020)
- 7.4 Japan Radiopharmaceuticals in Nuclear Medicine Production, Revenue and Growth Rate (2014-2020)
- 7.5 Korea Radiopharmaceuticals in Nuclear Medicine Production, Revenue and Growth Rate (2014-2020)
- 7.6 India Radiopharmaceuticals in Nuclear Medicine Production, Revenue and Growth Rate (2014-2020)
- 7.7 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Production, Revenue and Growth Rate (2014-2020)
- 7.8 South America Radiopharmaceuticals in Nuclear Medicine Production, Revenue and Growth Rate (2014-2020)
8 Global Radiopharmaceuticals in Nuclear Medicine Consumption Assessment
- 8.1 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Market Share by Regions (2014-2020)
- 8.2 Global Radiopharmaceuticals in Nuclear Medicine Consumption Value and Market Share by Regions (2014-2020)
- 8.3 Global Radiopharmaceuticals in Nuclear Medicine Average Price (USD/Unit) by Regions (2014-2020)
9 Global Radiopharmaceuticals in Nuclear Medicine Sales Assessment by Regions
- 9.1 Global Radiopharmaceuticals in Nuclear Medicine Sales and Sales Value (2014-2020)
- 9.2 China Radiopharmaceuticals in Nuclear Medicine Sales and Sales Value (2014-2020)
- 9.3 USA Radiopharmaceuticals in Nuclear Medicine Sales and Sales Value (2014-2020)
- 9.4 Europe Radiopharmaceuticals in Nuclear Medicine Sales and Sales Value (2014-2020)
- 9.5 Japan Radiopharmaceuticals in Nuclear Medicine Sales and Sales Value (2014-2020)
- 9.6 Korea Radiopharmaceuticals in Nuclear Medicine Sales and Sales Value (2014-2020)
- 9.7 India Radiopharmaceuticals in Nuclear Medicine Sales and Sales Value (2014-2020)
- 9.8 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales and Sales Value (2014-2020)
- 9.9 South America Radiopharmaceuticals in Nuclear Medicine Sales and Sales Value (2014-2020)
10 Technology and Cost
- 10.1 Technology
- 10.2 Cost
11 Channel Analysis
- 11.1 Market Channel
- 11.2 Distributors
12 Market Forecast 2021-2026
- 12.1 Production and Revenue Forecast 2021-2026
- 12.1.1 Global Radiopharmaceuticals in Nuclear Medicine Production and Revenue by Regions 2021-2026
- 12.1.2 China Radiopharmaceuticals in Nuclear Medicine Production, Revenue and Growth Rate 2021-2026
- 12.1.3 USA Radiopharmaceuticals in Nuclear Medicine Production, Revenue and Growth Rate 2021-2026
- 12.1.4 Europe Radiopharmaceuticals in Nuclear Medicine Production, Revenue and Growth Rate 2021-2026
- 12.1.5 Japan Radiopharmaceuticals in Nuclear Medicine Production, Revenue and Growth Rate 2021-2026
- 12.1.6 Korea Radiopharmaceuticals in Nuclear Medicine Production, Revenue and Growth Rate 2021-2026
- 12.1.7 India Radiopharmaceuticals in Nuclear Medicine Production, Revenue and Growth Rate 2021-2026
- 12.1.8 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Production, Revenue and Growth Rate 2021-2026
- 12.1.9 South America Radiopharmaceuticals in Nuclear Medicine Production, Revenue and Growth Rate 2021-2026
- 12.2 Sales and Sales Value Forecast 2021-2026
- 12.2.1 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Consumption Calue by Regions 2021-2026
- 12.2.2 Global Radiopharmaceuticals in Nuclear Medicine Sales and Sales Value Forecast 2021-2026
- 12.2.3 China Radiopharmaceuticals in Nuclear Medicine Sales, Sales Value and Growth Rate 2021-2026
- 12.2.4 USA Radiopharmaceuticals in Nuclear Medicine Sales and Sales Value Forecast 2021-2026
- 12.2.5 Europe Radiopharmaceuticals in Nuclear Medicine Sales and Sales Value Forecast 2021-2026
- 12.2.6 Japan Radiopharmaceuticals in Nuclear Medicine Sales and Sales Value Forecast 2021-2026
- 12.2.7 Korea Radiopharmaceuticals in Nuclear Medicine Sales and Sales Value Forecast 2021-2026
- 12.2.8 India Radiopharmaceuticals in Nuclear Medicine Sales and Sales Value Forecast 2021-2026
- 12.2.9 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales and Sales Value Forecast 2021-2026
- 12.2.10 South America Radiopharmaceuticals in Nuclear Medicine Sales and Sales Value Forecast 2021-2026
- 12.3 Global Radiopharmaceuticals in Nuclear Medicine Production and Revenue Forecast by Type 2021-2026
- 12.3.1 Overall Market Performance
- 12.3.2 Diagnostic Radiopharmaceuticals
- 12.3.3 Therapy Radiopharmaceuticals
- 12.3.4 Enriched Stable Isotopes
- 12.4 Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Application 2021-2026
- 12.4.1 Overall Market Performance
- 12.4.2 Diagnostic Application
- 12.4.3 Therapeutic Application
- 12.4.4 Research
- 12.4.5 Pharmaceutical
- 12.4.6 Other
- 12.5 Global Radiopharmaceuticals in Nuclear Medicine Price and Gross Margin Forecast
- 13.5.1 Global Radiopharmaceuticals in Nuclear Medicine Averages Price Development Trend Forecast 2021-2026
- 13.5.2 Global Radiopharmaceuticals in Nuclear Medicine Gross Margin Development Trend Forecast 2021-2026
13 Conclusion
Summary:
Get latest Market Research Reports on Radiopharmaceuticals in Nuclear Medicine. Industry analysis & Market Report on Radiopharmaceuticals in Nuclear Medicine is a syndicated market report, published as Global Radiopharmaceuticals in Nuclear Medicine Market Research Report 2020 by Manufacturers, Regions, Types and Applications. It is complete Research Study and Industry Analysis of Radiopharmaceuticals in Nuclear Medicine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
